This report is being conservatively filed for tissue injury, possibly device related.It was reported that on (b)(6) 2022, a mitraclip procedure was scheduled.The right femoral access was performed, and the transeptal catheter was advanced with difficulty.Following, the steerable guide catheter (sgc) was unable to advance through the very tortuous iliac artery.The device was removed without an issue reported.Once removed, the guide shaft appeared indented (deformed).There appeared to be some dye extravasation surrounding the tissue at the point of stenosis and where the guide was removed.No additional treatment was provided.The procedure was aborted.No clip was attempted.No additional information was provided regarding this issue.
|
Medical device code 2017 applied for failure to follow instructions.The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents reported from this lot.Based on available information, the cause of the reported unspecified tissue injury (no treatment) associated with the injury at the site the steerable guide catheter (sgc) could not advance beyond, and the reported deformation due to compressive stress (shaft) associated with the kinked shaft, were due to stress put on the device from the failure to advance.The reported failure to advance associated with the inability to advance the sgc past the iliac vein was due to challenging patient anatomy (very tortuous iliac vein).The reported improper or incorrect procedure or method (failure to follow steps / instructions) was associated with advancing the sgc dilator 20cm past the tip of the sgc.The reported patient effect of tissue injury, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported serious injury/ illness/ impairment was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|